BioCatalyst

CLLS — Cellectis S.A. catalysts

1 verified catalyst event(s) for Cellectis S.A. (ticker CLLS). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-06-30 — Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymp · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-06-30
in 8d
ESTIMATED
 READOUT
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell
Phase 1/2 · B-cell Acute Lymphoblastic Leukemia
 CLLS Cellectis S.A. UCART22, CLLS52 ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.